| Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy YC Wang, X Wang, J Yu, F Ma, Z Li, Y Zhou, S Zeng, X Ma, YR Li, A Neal, ... Nature communications 12 (1), 3530, 2021 | 88 | 2021 |
| Creatine uptake regulates CD8 T cell antitumor immunity S Di Biase, X Ma, X Wang, J Yu, YC Wang, DJ Smith, Y Zhou, Z Li, YJ Kim, ... Journal of Experimental Medicine 216 (12), 2869-2882, 2019 | 88 | 2019 |
| Development of hematopoietic stem cell-engineered invariant natural killer T cell therapy for cancer Y Zhu, DJ Smith, Y Zhou, YR Li, J Yu, D Lee, YC Wang, S Di Biase, ... Cell Stem Cell 25 (4), 542-557. e9, 2019 | 65 | 2019 |
| Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy YR Li, Y Zhou, YJ Kim, Y Zhu, F Ma, J Yu, YC Wang, X Chen, Z Li, S Zeng, ... Cell Reports Medicine 2 (11), 2021 | 64 | 2021 |
| Interleukin 15 in cell-based cancer immunotherapy Y Zhou, T Husman, X Cen, T Tsao, J Brown, A Bajpai, M Li, K Zhou, ... International Journal of Molecular Sciences 23 (13), 7311, 2022 | 47 | 2022 |
| Targeting monoamine oxidase A for T cell–based cancer immunotherapy X Wang, B Li, YJ Kim, YC Wang, Z Li, J Yu, S Zeng, X Ma, IY Choi, ... Science immunology 6 (59), eabh2383, 2021 | 42 | 2021 |
| Circulating concentrations of growth differentiation factor 11 are heritable and correlate with life span Y Zhou, Z Jiang, EC Harris, J Reeves, X Chen, R Pazdro Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2016 | 37 | 2016 |
| Engineering induced pluripotent stem cells for cancer immunotherapy Y Zhou, M Li, K Zhou, J Brown, T Tsao, X Cen, T Husman, A Bajpai, ... Cancers 14 (9), 2266, 2022 | 32 | 2022 |
| Engineering stem cells for cancer immunotherapy YR Li, Y Zhou, A Kramer, L Yang Trends in cancer 7 (12), 1059-1073, 2021 | 29 | 2021 |
| Genetic analysis of tissue glutathione concentrations and redox balance Y Zhou, DE Harrison, K Love-Myers, Y Chen, A Grider, K Wickwire, ... Free Radical Biology and Medicine 71, 157-164, 2014 | 29 | 2014 |
| Human γδ T cell subsets and their clinical applications for cancer immunotherapy D Lee, CJ Rosenthal, NE Penn, ZS Dunn, Y Zhou, L Yang Cancers 14 (12), 3005, 2022 | 24 | 2022 |
| Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention YR Li, ZS Dunn, G Garcia Jr, C Carmona, Y Zhou, D Lee, J Yu, J Huang, ... Stem cell research & therapy 13 (1), 112, 2022 | 18 | 2022 |
| Development of stem cell-derived immune cells for off-the-shelf cancer immunotherapies YR Li, ZS Dunn, Y Zhou, D Lee, L Yang Cells 10 (12), 3497, 2021 | 16 | 2021 |
| Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers YR Li, S Zeng, ZS Dunn, Y Zhou, Z Li, J Yu, YC Wang, J Ku, N Cook, ... Iscience 25 (9), 2022 | 14 | 2022 |
| Tumor-localized administration of α-GalCer to recruit invariant natural killer T cells and enhance their antitumor activity against solid tumors YR Li, Y Zhou, M Wilson, A Kramer, R Hon, Y Zhu, Y Fang, L Yang International Journal of Molecular Sciences 23 (14), 7547, 2022 | 11 | 2022 |
| Methods for studying mouse and human invariant natural killer T cells Y Zhou, YR Li, S Zeng, L Yang Invariant natural killer T-cells: Methods and protocols, 35-57, 2021 | 10 | 2021 |
| Heritability of the aged glutathione phenotype is dependent on tissue of origin RL Gould, Y Zhou, CL Yakaitis, K Love, J Reeves, W Kong, E Coe, Y Xiao, ... Mammalian Genome 29, 619-631, 2018 | 9 | 2018 |
| Genetic influence on splenic natural killer cell frequencies and maturation among aged mice SA Bumgardner, Y Zhou, Z Jiang, EJ Coe, CL Yakaitis, Y Xiao, R Pazdro Experimental Gerontology 104, 9-16, 2018 | 6 | 2018 |
| Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers. iScience 25, 104859 YR Li, S Zeng, ZS Dunn, Y Zhou, Z Li, J Yu, YC Wang, J Ku, N Cook, ... | 5 | 2022 |
| Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy YR Li, Y Zhou, J Yu, Y Zhu, D Lee, E Zhu, Z Li, YJ Kim, K Zhou, Y Fang, ... Molecular Therapy 32 (6), 1849-1874, 2024 | 3 | 2024 |
